Skip to main content
Clinical Trials/NCT03612076
NCT03612076
Completed
Not Applicable

Cost of Failure Following Reimplantation After a 2-stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection

Hospices Civils de Lyon1 site in 1 country115 target enrollmentDecember 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prosthetic Joint Infection
Sponsor
Hospices Civils de Lyon
Enrollment
115
Locations
1
Primary Endpoint
Global cost of management of PJI
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study concerns patients having had an infection on their prosthesis (hip, knee,..) and for whom a 2-step exchange of prosthesis has been done.

A 2-step exchange consists in explantation of the prosthesis and implementation of a spacer at the first stage, and reimplantation of a new prosthesis in a second stage. Patients with late prosthetic joint infection are at risk for superinfection at the time of reimplantation.

The aim of this study is to determine the global cost of management of prosthetic joint infection.

Registry
clinicaltrials.gov
Start Date
December 1, 2016
End Date
July 1, 2018
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patients with prosthetic joint infection having had a 2-step exchange and managed at the CRIOAc from at least the reimplantation (between 2013 and 2015)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Global cost of management of PJI

Time Frame: Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)

The following data are collected : duration of hospitalization at the Croix Rousse hospital (surgery unit, department of infectiology, other...) and in post-acute care structures, bacteriology, surgeries, medical treatments... and all acts realized throughout the management of the PJI.

Study Sites (1)

Loading locations...

Similar Trials